Silenseed announced a new company’s United States Patent No. 9,687,500, named “Methods and Compositions for Treating Cancer”

Silenseed announced today (June 27, 2017) the new company’s United States Patent No. 9,687,500, named “Methods and Compositions for Treating Cancer”. The 9,687,500 patent details the treatment of cancer by regional and prolonged release of one or more nucleotide-based agents, targeting oncogenes including the polycomb ring finger oncogene (BMI-1).